Cardiosonic
Cardiosonic is specialized in the diagnosis and treatment of heart and respiratory diseases affecting dogs and cats.
Cardiosonic has raised €4.7M across 1 funding round from 1 investor, most recently a Series B round in Dec 2012. Based in Spain; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.7M
€4,697,366
Funding rounds
1
Investors
1
distinct backers
Active since
2012-12
latest 2012-12
Funding by year
EUR raised per yearCardiosonic — funding by year — interactive chart.
Data table
| Cardiosonic — funding by year | |
|---|---|
| 2012 | €4.7M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-12-01 | Series B | €4.7M | Shmuel Almagor | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData